Literature DB >> 11035279

Chronic hypoxia and developmental regulation of cytochrome c expression in rats.

D Xiao1, C A Ducsay, L Zhang.   

Abstract

OBJECTIVE: To test the hypothesis that chronic hypoxia upregulates cytochrome c expression in heart, brain, and liver of fetal and maternal rats.
METHODS: Time-dated pregnant Sprague-Dawley rats were divided into normoxic and hypoxic (48 hours of 10.5% oxygen from days 19 to 21) groups, and were killed on day 21. Tissue levels of cytochrome c in heart, brain, and liver were determined by using monoclonal antiserum for cytochrome c.
RESULTS: Chronic hypoxia caused a decrease in fetal body weight (5.3 +/- 0.1 to 4.7 +/- 0.1 g) and an increase in heart/body weight ratio (0.0048 +/- 0.0001 to 0.0061 +/- 0.0002). Cytochrome c levels were 4-, 2.6-, and 13-fold higher in heart, liver, and brain, respectively, of the mother than of the fetus. Chronic hypoxia did not change cytochrome c levels in maternal tissues but caused a 70% increase and 54% decrease in cytochrome c levels in the fetal heart and liver, respectively. No difference was observed in the fetal brain.
CONCLUSIONS: The results suggest that expression of cytochrome c is tissue specific and developmentally regulated. Chronic hypoxia showed differential regulation of cytochrome c levels both developmentally and tissue specifically. The increased sensitivity of cytochrome c in fetal tissue to chronic hypoxia is likely to represent a fetal adaptive mechanism to the stress of chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035279

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  16 in total

Review 1.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Foetal hypoxia impacts methylome and transcriptome in developmental programming of heart disease.

Authors:  Lei Huang; Xin Chen; Chiranjib Dasgupta; Wanqiu Chen; Rui Song; Charles Wang; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

3.  Mechanisms of developmental programming of the metabolic syndrome and related disorders.

Authors:  Zhong-Cheng Luo; Lin Xiao; Anne-Monique Nuyt
Journal:  World J Diabetes       Date:  2010-07-15

4.  Prenatal cocaine exposure increases apoptosis of neonatal rat heart and heart susceptibility to ischemia-reperfusion injury in 1-month-old rat.

Authors:  Soochan Bae; Lubo Zhang
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 5.  Hypoxia and fetal heart development.

Authors:  A J Patterson; L Zhang
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

6.  Promoter methylation of Egr-1 site contributes to fetal hypoxia-mediated PKCε gene repression in the developing heart.

Authors:  Man Chen; Fuxia Xiong; Lubo Zhang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

7.  Developmental programming resulting from maternal obesity in mice: effects on myocardial ischaemia-reperfusion injury.

Authors:  John W Calvert; David J Lefer; Susheel Gundewar; Lucilla Poston; William A Coetzee
Journal:  Exp Physiol       Date:  2009-04-24       Impact factor: 2.969

8.  Prenatal nicotine exposure increases heart susceptibility to ischemia/reperfusion injury in adult offspring.

Authors:  Jennifer Lawrence; Daliao Xiao; Qin Xue; Maryam Rejali; Shumei Yang; Lubo Zhang
Journal:  J Pharmacol Exp Ther       Date:  2007-10-18       Impact factor: 4.030

9.  Early fetal hypoxia leads to growth restriction and myocardial thinning.

Authors:  Margie Ream; Alisa M Ray; Rashmi Chandra; Dona M Chikaraishi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-28       Impact factor: 3.619

Review 10.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.